Compugen Alternatives & Competitors
12 companies similar to Compugen — A clinical-stage cancer immunotherapy company and a pioneer in computational tar...
Companies similar to Compugen
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hummingbird Bioscience
Hummingbird Bioscience is a biotherapeutics company working at the interface of AI and hum...
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Valink Therapeutics
Making better ADCs
Rival Readout
Competing with Compugen? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Relay Therapeutics
Integrating leading-edge computational and experimental science to transform human health....
iktos
Artificial intelligence for new drug design
MediMabBio
A biotechnology company that focuses on developing new therapeutic drugs targeting Oncolog...
PMV Pharmaceuticals, Inc.
Harnessing the power of p53 to treat cancer
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to t...
Bright Biologics
Developing bispecific antibody drug to improve cancer treatment.
About Compugen
Compugen is a clinical-stage company specializing in cancer immunotherapy, leveraging its AI/ML-powered computational discovery platform, Unigen™. Founded in 1993, this Israel-based firm is recognized for its pioneering role in computational target discovery. Compugen's innovative pipeline includes proprietary programs...
Drug Discovery, Clinical Trials, Therapeutic Development, AI/ML Application in Drug Research
Pharmaceutical Companies, Biotech Investors, Healthcare Providers, Cancer Research Organizations, Oncology Researchers
Cancer Immunotherapy, Computational Target Discovery, AI/ML Powered Discovery, Fc-reduced Antibodies, Bispecific Antibody Development, TIGIT Targeting Programs, PD-1/TIGIT Bispecific Antibodies, Immuno-Oncology, In Silico Prediction, Pharmaceutical Partnerships, Machine Learning Systems, Drug Development Pipeline, Therapeutic Discovery, In Silico Hypothesis-Driven Discovery, Experimental Validation
B2B
Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Compugen: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Compugen on 22 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.